ArticleFrontiers in oncology2026

Exploring the pharmacological mechanisms of resibufogenin in castration-resistant prostate cancer via network pharmacology and experimental validation.

Yuanxin Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.